PATH EX, Inc. Announces Successful $5 Million Financing Round to Advance CycloPE(R), a Breakthrough Treatment for Sepsis
HOUSTON, TEXAS / ACCESS Newswire / May 8, 2025 / PATH EX, Inc., a medical device company located in the Texas Medical Center Innovation Factory, is excited to announce the successful completion of a $5 million financing round. This investment... Read More →
Bobby Reddy Jr from Presnosis makes TIME’s 100 list
Every year in the U.S., about 6% of emergency room visits are due to sepsis, an extreme immune system reaction to infection that can lead to organ failure and death in a short period of time. Anywhere from 30% to... Read More →
Conavi Medical’s Novasight Hybrid™ System Named “Product Innovation of the Year” at 2025 Minnesota Manufacturing Awards
Award recognizes Novasight Hybrid™ System’s significant advance in intracoronary imaging technology TORONTO, May 08, 2025 (GLOBE NEWSWIRE) — Conavi Medical Corp. (TSXV: CNVI; OTCQB: CNVIF) (“Conavi Medical” or the “Company”), a medical device company focused on designing, manufacturing, and marketing... Read More →
GenNext Technologies and Thermo Fisher Scientific Collaborate to Simplify Structural Biology for Faster Biotherapeutic Development
New Workflow Streamlines Protein Structural Analysis and Supports the Growing Role of AI in Drug Discovery Half Moon Bay, CA – May 7, 2025 – GenNext® Technologies, Inc., a pioneer in protein footprinting, is collaborating with Thermo Fisher Scientific, the... Read More →
INBRAIN Neuroelectronics Awarded €4 Million Grant from Spain’s PERTE Chip Program to Advance Graphene-Based Brain-Computer Interfaces
BARCELONA, Spain–(BUSINESS WIRE)–INBRAIN Neuroelectronics, a clinical-stage neurotechnology company developing precision brain-computer interfaces (BCIs) powered by graphene, announced today it has been awarded a €4 million grant by the Spanish Ministry of Industry and Tourism through the PERTE Chip initiative. The... Read More →
Zetagen Therapeutics Announces Successful Completion of Enrollment in Phase 2a Clinical Study of ZetaMet™ (Zeta-BC-003) Metastatic Breast Cancer
(690,000 patients annually are diagnosed with metastatic lytic bone lesions with only non-curative, palliative therapies available) ZetaMet™ (Zeta-BC-003) is a first-of-its kind molecular pathway designed to resolve metastatic cancer lesions, inhibit pain, and regenerate bone Phase 2a study examines the... Read More →
Remidio receives CDSCO approval for AI Tools to Detect Glaucoma and AMD
State FDA, Karnataka, clears Medios HI Glaucoma AI and Medios HI AMD AI for nationwide use, expanding access to early detection tools in ophthalmology Remidio Innovative Solutions has received regulatory approval from the State FDA, Karnataka (CDSCO) for its AI-based... Read More →
Cosmo Announces EU MDR Certification for Endovision’s Cerebro, expanding its real-time AI ecosystem
Dublin, Ireland – May 2, 2025: Cosmo is excited to announce that Endovision Limited, a leading innovator in endoscopic imaging solutions, has received EU MDR certification[1] for Cerebro, a Real-Time AI-powered guide for complete Esophagogastroduodenoscopy (EGD) procedures. As one of... Read More →
SafeHeal nets $40m to advance endoluminal bypass sheath
The funds will support the completion of SafeHeal’s IDE pivotal study and ensuing commercialisation efforts for its Colovac sheath. SafeHeal has pulled in €35m ($39.7m) in Series C equity financing to validate its Colovac endoluminal bypass system. The oversubscribed funding... Read More →
Iceland: Sidekick Health Secures €35 Million Venture Debt from EIB to Accelerate R&D and Global Expansion
The European Investment Bank (EIB) and Sidekick Health — a global leader in integrated digital health and therapeutics — today announced the signing of a €35 million venture debt facility, backed by a dedicated life science venture debt window of... Read More →